19081-Lung Cancer-NA-129

Lung Cancer

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b (MER-XMT-1536-1)

  • Details

ClinicalTrials.gov ID: NCT03319628
Diagnosis Type: NA
USOR Number: 19081

  • Address

1800 Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.